These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7279827)

  • 1. 'Pulse' methylprednisolone and cyclophosphamide therapy in idiopathic rapidly progressive glomerulonephritis.
    Friedman G; Granot H; Koplovic Y; Friedlander M
    Postgrad Med J; 1981 Jan; 57(663):54-6. PubMed ID: 7279827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of progressive necrotizing vasculitis with intravenous pulse cyclophosphamide and methylprednisolone.
    Fort JG; Abruzzo JL
    Arthritis Rheum; 1988 Sep; 31(9):1194-8. PubMed ID: 3422017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous pulse methylprednisolone therapy of acute crescentic rapidly progressive glomerulonephritis.
    Bolton WK; Couser WG
    Am J Med; 1979 Mar; 66(3):495-502. PubMed ID: 433955
    [No Abstract]   [Full Text] [Related]  

  • 4. Pulse methylprednisolone therapy in idiopathic, rapidly progressive glomerulonephritis.
    Oredugba O; Mazumdar DC; Meyer JS; Lubowitz H
    Ann Intern Med; 1980 Apr; 92(4):504-6. PubMed ID: 7362154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylprednisolone and cyclophosphamide pulse therapy in crescentic glomerulonephritis: safety and effectiveness.
    Rondeau E; Kourilsky O; Peraldi MN; Alberti C; Kanfer A; Sraer JD
    Ren Fail; 1993; 15(4):495-501. PubMed ID: 8210561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined cyclophosphamide and corticosteroid-induced remission in severe glomerulopathy associated with systemic vasculitis.
    Rubinger D; Drukker A; Shvil Y; Kopolovic Y; Friedlaender MM; Shalit M; Popovtzer MM
    Am J Nephrol; 1986; 6(5):346-52. PubMed ID: 2881483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylprednisolone pulse therapy in rapidly progressive glomerulonephritis.
    de Glas-Vos JW; Krediet RT; Arisz L
    Neth J Med; 1991 Apr; 38(3-4):96-103. PubMed ID: 1881508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylprednisolone pulse therapy in the treatment of polyarteritis nodosa.
    Neild GH; Lee HA
    Postgrad Med J; 1977 Jul; 53(621):382-7. PubMed ID: 18728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monthly cyclophosphamide pulses in the treatment of crescentic glomerulonephritis.
    De La Torre M; Alcázar R; Urra JM; Caparrós G; Alegre R; Blanco J; Nieto J; Ferreras I
    Transplant Proc; 1998 Dec; 30(8):3952-4. PubMed ID: 9865259
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of rapidly progressive glomerulonephritis due to Behçet's syndrome with intravenous cyclophosphamide.
    Tietjen DP; Moore WJ
    Nephron; 1990; 55(1):69-73. PubMed ID: 2191233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cyclophosphamide pulse therapy in patients with primary glomerulonephritis].
    Rutkowski B; Wielgosz A; Manitius J; Bułło B; Kowalewska J; Tylicki L; Roszkiewicz A
    Przegl Lek; 2000; 57(11):624-7. PubMed ID: 11293209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful management of idiopathic rapidly progressive glomerulonephritis with corticosteroids and cytotoxic agent.
    Adhikary L; Simkhada R
    Kathmandu Univ Med J (KUMJ); 2005; 3(3):289-91. PubMed ID: 18650595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of membranous nephropathy to acute crescentic rapidly progressive glomerulonephritis and response to pulse methylprednisolone.
    Koethe JD; Gerig JS; Glickman JL; Sturgill BC; Bolton WK
    Am J Nephrol; 1986; 6(3):224-8. PubMed ID: 3740132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Pulse' methylprednisolone therapy in the treatment of acute crescentic glomerulonephritis.
    Ferraris JR; Gallo GE; Ramirez J; Iotti R; Gianantonio C
    Nephron; 1983; 34(3):207-8. PubMed ID: 6877456
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravenous pulse methylprednisolone therapy of acute primary crescenteric rapidly progressive glomerulonephritis.
    Tallgren LG
    Scand J Rheumatol Suppl; 1984; 54():24-6. PubMed ID: 6592752
    [No Abstract]   [Full Text] [Related]  

  • 16. Short- and long-term effects of methylprednisolone pulses and oral cyclophosphamide in renal micropolyarteritis.
    Salvidio G; Garibotto G; Trivelli A; Moggia E; Villaggio B; Tizianello A
    Contrib Nephrol; 1991; 94():144-50. PubMed ID: 1687273
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic studies in NZB/W mice. III. Relationship between renal status and efficacy of immunosuppressive drug therapy.
    Steinberg AD; Gelfand MC; Hardin JA; Lowenthal DT
    Arthritis Rheum; 1975; 18(1):9-14. PubMed ID: 1115749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined suppressive drug treatment in severe refractory rheumatoid disease: an analysis of the relative effects of parenteral methylprednisolone, cyclophosphamide, and sodium aurothiomalate.
    Walters MT; Cawley MI
    Ann Rheum Dis; 1988 Nov; 47(11):924-9. PubMed ID: 3144941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous "pulse" cyclophosphamide therapy of crescentic glomerulonephritis.
    Kunis CL; Kiss B; Williams G; D'Agati V; Appel GB
    Clin Nephrol; 1992 Jan; 37(1):1-7. PubMed ID: 1541058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Henoch-Schönlein Purpura glomerulonephritis in children with high-dose corticosteroids plus oral cyclophosphamide.
    Flynn JT; Smoyer WE; Bunchman TE; Kershaw DB; Sedman AB
    Am J Nephrol; 2001; 21(2):128-33. PubMed ID: 11359020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.